CHANGE IN RATINGS
downgraded at Goldman Sachs to Neutral from Buy. Price target cut to $24 from $27.
downgraded at Goldman Sachs to Neutral from Buy. Shares now trade above $36 price target.
upgraded at Goldman Sachs to Buy from Neutral. Price target at $62.
upgraded at Credit Suisse from Neutral to Outperform. $165 price target.
upgraded at Goldman to Buy from Neutral. Price target at $61.
downgraded at Barclays to Equal-weight from Overweight. Price target lowered to $1 from $8. Lowers 2009 EPS estimates.
downgraded at Jefferies to Hold from Buy. Price target reduced to $80 from $98.
downgraded at Barclays from Equal-weight to Underweight. $1 price target.
downgraded at Goldman Sachs to Sell from Neutral due to sharp reductions in 2009 outlook. Price target slashed to $6 from $14.
downgraded at UBS to Neutral from Buy. Maintains $70 price target.
downgraded at Argus to Hold. Estimates also cut.
downgraded at KBW from Outperform to Market Perform. $25 price target.
upgraded at Credit Suisse to Outperform.
upgraded at Goldman Sachs to Buy from Neutral. Price target at $17.
downgraded at Oppenheimer to Perform from Outperform and price target removed.
downgraded at Goldman Sachs to Neutral from Buy. Price target lowered to $7 from $11.
STOCK COMMENTS / EPS CHANGES
estimates raised at UBS. 2009 estimate increased to $5.24 a share. Buy rating and $91 price target.
numbers cut at Barclays through 2009. Underweight rating and new $0.50 price target.
estimates cut at UBS. 2010 estimate lowered to $3.25 a share. Neutral rating and $31 price target.
numbers lowered at Barclays. Shares now seen reaching $15. Equal-weight rating.
estimates increased at UBS. 2009 estimates raised to $5.30 a share. Neutral rating and $84 price target.
STRATEGY CALLS / MARKET CALLS
Bank targets, estimates cut at Morgan Stanley. Shares of
Bank of America
now seen reaching $16. Price target on
lowered to $8. Estimates cut for both firms, as well as
, which may cut its dividend 30%.
This article was written by a staff member of TheStreet.com.